CYBO is a biotechnology startup based in Japan, founded in 2018. The company's slogan, "Cytometry Innovates", reflects its primary focus on developing innovative cytometry and cell sorting platforms for life science experts. With a recent ¥400.00M Series A investment on 13 June 2023 led by Incubate Fund and JAFCO Japan, CYBO has attracted attention from prominent investors, signaling a potential for future growth and expansion. The infusion of capital will likely facilitate the further development and commercialization of their cutting-edge technologies, positioning CYBO as a key player in the biotechnology industry.
CYBO
Cytometry Innovates
Founded 2018
Japan
21 employees
Series A
Total: $460.00M
Biotechnology, Life Sciences
Japan
21 employees
Series A
Total: $460.00M
Biotechnology, Life Sciences
General Information
Company Name
CYBO
Founded Year
2018
Location
Japan
Japan
Founders / Decision Makers
Employees
21
Industries
Biotechnology, Life Sciences
Funding Stage
Series A
BounceWatch is an independent company data service, not affiliated with CYBO. To contact CYBO, visit cybo.jp.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does CYBO compare?
A PDF of CYBO and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting CYBO soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
Japan Market
Biotechnology
About CYBO
Taxonomy: Cytometry, Cell sorting, Life sciences, Cell analysis, High-speed imaging, Artificial intelligence, Image processing, Medication manufacturing, Food industry, Illness diagnosis, Cell measurement, Software technology, Hardware technology, Innovation
Funding Rounds & Investors (2)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series A | ¥400.00M | 2 |
|
13 Jun 2023 |
| Seed Round | ¥60.00M | 1 |
|
01 Oct 2020 |
CYBO Alternatives & Competitors
View All Alternatives
CYBO vs
TARGAN Inc.
United States
Bio-systems company focused on improving animal health and productivity in the poultry industry.
Series C
112 employees
Biotechnology, Life Sciences
CYBO vs
Vizgen
United States
Confidently take your research to new depths with MERSCOPE Ultra integrating single-cell and spatial...
Series E
153 employees
Biotechnology, Health Care
CYBO vs
Empowering precision medicine through a pioneering cell-based informatics platform, delivering cruci...
Venture round
Biotechnology, Health Care
FAQ About CYBO
Cytometry Innovates
CYBO was founded in 2018.
CYBO is headquartered in Japan.
CYBO operates in Biotechnology and Life Sciences. Its work centres on Cytometry, Cell sorting, Life sciences and Cell analysis.
CYBO has approximately 21 employees.
CYBO has completed 2 funding rounds, raising a total of $460.00M. The latest funding stage is Series A.
Top alternatives and competitors to CYBO include TARGAN Inc., Vizgen, Cytovas, Namocell, STEMCELL Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CYBO and TARGAN Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.
Source: BounceWatch company record for CYBO, https://bouncewatch.com/company/cybo, updated 14 January 2025. When citing, please name BounceWatch and link this page.
